Tharimmune, Inc. - Common Stock THAR 深 沪
已收盘 10-10 16:00:00 美东时间
2.98
-0.180
-5.70%
华盛通- 最 高3.52
- 今 开3.22
- 成交量 63.86万股
- 最 低 2.95
- 昨 收 3.16
- 总市值 1257.83万
- 52周最高 9.08
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 0.952
- 委 比 -18.73%
- 总股本 422.09万
- 历史最高 1590.00
- 量 比 2.25
- 振 幅 18.04%
- 历史最低 0.952
- 每 手 1
- 风险率 0.91%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tharimmune Increases Total Number Of Common Stock Authorized For Issuance From 250M To 1B Shares
On October 10, 2025, Tharimmune, Inc. (the "Company") filed a Certificate of Amendment (the "Amendment") to its Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware pursuant to
10-11 04:24
Tharimmune Stockholders Approve Key Strategic Proposals
The latest announcement is out from Tharimmune ( ($THAR) ). On October 9, 2025,...
10-10 04:55
Tharimmune Amends Warrants Agreement to Boost Liquidity
Tharimmune ( ($THAR) ) has issued an update. On October 1, 2025, Tharimmune, In...
10-06 20:53
Why MBX Biosciences Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket
Shares of MBX Biosciences, Inc. (NASDAQ:MBX) rose sharply in pre-market trading...
09-22 17:46
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
Tharimmune, Inc. will present new results at three upcoming conferences: October 24-29, 2025, at the ACG Annual Scientific Meeting in Phoenix, AZ; November 7-10, 2025, at the AASLD Annual Conference in Washington, DC; and November 9-12, 2025, at the AAPS PharmSci 360 in San Antonio, TX. The company is focused on developing therapeutic candidates for inflammation, immunology, and oncology, including its lead asset TH104 for respiratory and nervous...
09-04 12:01
Why Autodesk Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of Autodesk, Inc. (NASDAQ:ADSK) rose sharply in pre-market trading poste...
08-29 18:58
Reported August 26, 2025: Tharimmune Files Prospectus To Register ~2.46M Shares, Including PIPE And Warrant Shares
PRELIMINARY PROSPECTUSSubject to completion, dated August 26, 2025 2,463,601 Shares of Common Stock Pursuant to a registered direct offering and concurrent private placement which closed on July 28, 2025
08-27 23:00
Tharimmune Enters $5.35M Securities Purchase Agreement
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001861657/000164117225025476/form8-k.htm
08-26 21:37
Tharimmune (THAR) Shares Skyrocket On Promising Opioid Countermeasure Data
Shares of Tharimmune are surging Thursday afternoon. The company on Wednesday announced positive results from a simulation analysis of its lead clinical asset, TH104.
08-22 03:28
Why Is Tharimmune Stock (THAR) Exploding Higher?
Shares of Tharimmune, Inc. ($THAR) jumped 207% on Wednesday as the biotechnolog...
08-21 15:45
